ESR2 and urinary bladder carcinoma: The following are key molecules whose expression and/or activity have been shown to be modulated via the androgen-AR/estrogen-ERβ/glucocorticoid-GR signaling pathways in non-neoplastic urothelial (or bladder cancer) cells.